A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis
Clinical trial NCT05923099 · COMPLETED
Trial details
- NCT number
- NCT05923099
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2024-12-11
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.